The Senate passed a historic $2 trillion coronavirus relief package late Wednesday night to provide a jolt to an economy reeling from the coronavirus pandemic, capping days of intense negotiations that produced one of the most expensive and far-reaching measures Congress has ever considered.
Following up on a client alert we sent earlier this week regarding the COVID-19 bill package that Governor Phil Murphy signed into law, the New Jersey Economic Development Authority (the "EDA") today approved a package of grant and loan programs for small and mid-sized businesses and non-profits impacted by the coronavirus crisis.
Today we have set forth how major federal and state legislation, both long standing and recently enacted, come into play during this pandemic.
On March 20th, Governor Phil Murphy signed a package of bills into law aimed at alleviating the economic impact that the coronavirus may have on New Jersey businesses and residents.
Learn important highlights for businesses about Families First Coronavirus Response Act.
Yesterday, the New Jersey State Legislature sent Governor Phil Murphy a number of bills aimed at alleviating the economic impact that the coronavirus may have on New Jersey businesses.
The United States Treasury and the IRS confirmed today that due to the Coronavirus pandemic individuals and businesses will be allowed to defer their 2019 tax payments for up to 90 days (ie, from April 15, 2020 to July 15, 2020).
The Senate approved a multi-billion dollar emergency aid package Wednesday that will provide paid sick and family leave for many Americans while also offering free testing for the coronavirus and bolstering unemployment insurance.
On Monday, the New Jersey General Assembly approved the COVID-19 bill package to help businesses and New Jersey residents mitigate the economic challenges they may face due to the COVID-19 outbreak.
The New Jersey Compassionate Use Medical Marijuana Act (the "Compassionate Use Act") protects medicinal cannabis users with regard to the terms and conditions of employment. The Compassionate Use Act expressly prohibits an employer from taking any adverse employment action against a medical cannabis user if that adverse employment action is based "solely on the employee's status" as a medical cannabis patient.